Sai L Shankar

9PUBLICATIONS
29CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Medical virologyChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodies.

|Feb 18, 2026
Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.

Ahmed Z Obeidat, Michelle Betz, Rebecca Straus Farber

|Oct 07, 2025
Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy.

Cortnee Roman, Meghan Garabedian, Virginia R Schobel

|Jun 16, 2025
Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis.

Sophia Woodson, Edward J Gettings, Chu-Yueh Guo

|Jun 16, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA.

Sophia Woodson, Edward J Gettings, Chu-Yueh Guo

|Jun 27, 2024
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study.

Barry A Singer, Sibyl Wray, Mark Gudesblatt

Pageof 2

Frequent Collaborators

9 joint publications

James B Lewin

8 joint publications

Jason P Mendoza

3 joint publications

Boyang Bian

2 joint publications

Yang Mao-Draayer